semaglutide doctor rochester ny Medical Weight Support & Peptide Therapy Semaglutide 2.4 mg clinical outcomes

September 1, 2025: FDA Approves Wegovy for Fatty Liver Disease The FDA has granted a new indication for Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease in adults with moderate to advanced fibrosis

Our Registered Dietitian Lily lentil covers the key nutrients so that you can eat in a way that nourishes (not punishes) your body

E.WeigleD

Shima Hadidchi, MD, is dedicated to helping our patients find the most effective and personalized strategies for managing diabetes and supporting healthy weight goals

Your routine should target all major muscle groups using a variety of tools and techniques